Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression LevelsBiagio Ricciuti, Mark M. Awad, Rileen Sinha et al.|JAMA Oncology|2022Cited by 383
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim resultsChristine D. Palmer, Karin Jooss, Amy Rappaport et al.|Nature Medicine|2022Cited by 225
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancerArvind Ravi, Justin F. Gainor, Matthew D. Hellmann et al.|Nature Genetics|2023Cited by 185
Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastasesBenjamin Izar, Lindsay Caprio, Amit Dipak Amin et al.|Nature Medicine|2025Cited by 53
Quantitative tissue analysis and role of myeloid cells in non-small cell lung cancerBrian S. Henick, Kurt A. Schalper|Journal for ImmunoTherapy of Cancer|2022Cited by 9